Armen Yuri Gasparyan
Dr. Armen Yuri Gasparyan has been involved in clinical research on cardiovascular issues in inflammatory disorders since 1994, and got his PhD degree in 2002. He was a trainer of English speaking medical students (Yerevan, 2003-2008) and awarded an academic title of Associate Professor of medicine in 2006. Since 2007, he has been post-doctoral research fellow in thrombosis and cardiovascular rheumatology in the UK, supported by the European Society of Cardiology and the European League Against Rheumatism. In 2010, he was awarded title of Fellow of the European Society of Cardiology (FESC). As a clinical lecturer, he delivered lectures on the whole course of internal medicine, developed evidence-based clinical guidelines for general practitioners and a textbook on internal medicine. Over the past four years, he also organized international seminars on science editing in the UK, Turkey, Iran, and Spain. He is a reviewer at The Lancet, Atherosclerosis, Thrombosis and Haemostasis, Thrombosis Research, Journal of Human Hypertension, Rheumatology (Oxford), Seminars in Arthritis and Rheumatism, Current Pharmaceutical Design, Platelets, Rheumatology International, Academic Medicine and some other indexed journals (since 2006). He is also a guest editor of Current Pharmaceutical Design, Deputy Editor-in-Chief of Inflammation and Allergy - Drug Targets, member of editorial board of Atherosclerosis, Thrombosis Research, Vascular Health and Risk Management, Rheumatology International and Current Vascular Pharmacology. In 2007-2010, Dr A.Y.Gasparyan served as the executive editor of Archives of Medical Science (Poland), and joined the World Association of Medical Editors (2008) and the European Association of Science Editors (2009). Since 2011, he is chief editor of European Science Editing and council member of the European Association of Science Editors. A.Y. Gasparyan published numerous papers, reviews and editorials, including the following highly cited articles: 1. [Gasparyan AY, et al. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 2010;8(4):437-449. ], 2. [Gasparyan AY, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011;17(1):47-58. ], 3. [Gasparyan AY, et al. The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 2008;51(19):1829-1843.].